Overview

Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa

Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
Pharmacokinetic (PK) study to characterize changes in serum concentrations in epilepsy patients when switching from LAMICTAL immediate-release to extended-release and vice versa.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Lamotrigine